| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10222467 | American Journal of Preventive Medicine | 2018 | 10 Pages |
Abstract
Two decades of evidence support metformin use for diabetes prevention among higher-risk patients. However, metformin is not widely used in real-world practice, and enhancing the translation of this evidence to real-world practice has important implications for patients, providers, and payers.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Tannaz MD, MBA, MSHS, Julie A. PhD, James H. MD, MSCE, Jessica PhD, Andrew J. PhD, Lydia E. MD, Dean MD, Carol M. MD, MSPH, William H. MD, MPH, Elizabeth A. PhD, RN,